Vaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...

Until recently, Kedar was Vice President, Global Generics Finance and Head of Investor Relations in Dr Reddy's Laboratories, Cipla said in ...

India's third largest drug maker Cipla has created a five member management council, led by CEO Subhanu Saxena as part of its transformatio...

"We are very happy with our strong results this quarter and growth momentum has continued for the first half of the year."

Cipla Ltd today appointed former head of Dr Reddy's North American business Umang Vohra as its Global Chief Financial and Strategy Officer.

Cipla has said it is not "compelled" to go in for major M&As, preferring instead a semi-inorganic route to expand its global footprint.

Kamil Hamied has quit Cipla, surprising those who had expected him to take a leadership role at India’s third-largest drug company.

Over the 2-year period with Subhanu Saxena at the helm, Cipla's revenues have grown by over 30% to nearly Rs 11,500 crore.

Cipla's stock surged 3.23 per cent to settle at Rs 618.60 on the BSE. In intra-day, it climbed 4.13 per cent to Rs 624.

Cipla has launched multiple respiratory products in Europe this year, and launch of some key inhalers is expected in 2015.

Cipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug O...

The collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively sell Teva’s broad pharmaceutical product po...

The sector has slowed from its peak growth rate, the lure of expansion in the Rs 75,000-crore pharma market has kept companies looking for ...

Cipla will prioritise emerging markets across the African continent in its growth plans, the company's CEO Subhanu Saxena has said.

Cipla's new initiative comes at a time when the company is making bold moves in expanding its international business.

Subhanu comes to Cipla with a diverse work experience across sectors, companies and locations such as Europe, North America, Africa and Asi...

The total consideration payable by Cipla is approximately $ 512 million or ZAR 4.5 billion.